Methyl 2-hydroxy-3-methylpentanoate
Common Name: |
Methyl 2-hydroxy-3-methylpentanoate |
IUPAC Name: |
methyl 2-hydroxy-3-methylpentanoate |
Molecular Formula: |
C10H20O2 |
SMILES: |
CCC(C)C(C(=O)OC)O |
Inchi: |
1S/C7H14O3/c1-4-5(2)6(8)7(9)10-3/h5-6,8H,4H2,1-3H3 |
Inchi Key: |
OQXGUAUSWWFHOM-UHFFFAOYSA-N |
Cas No: |
41654-19-7 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
172.26 |
Mass (g/mol) |
146.094 |
Molar Refractivity |
51.47 |
Net Charge |
|
HBD |
|
HBA |
2 |
Rt Bonds |
7 |
Rings |
|
TPSA |
26.30 |
Hetero Atoms |
3 |
Heavy Atoms |
12 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
181.00 to 182.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.247 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.90 |
LogP |
0.566 |
iLOGP |
2.73 |
XLOGP3 |
3.41 |
WLOGP |
2.91 |
MLOGP |
2.58 |
ESOL Log S |
-2.59 |
ESOL Solubility (mg/ml) |
0.438 |
ESOL Solubility (mol/l) |
0.003 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-3.64 |
Ali Solubility (mg/ml) |
0.04 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-2.80 |
Silicos-IT Solubility (mg/ml) |
0.27 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-4.93 |
Bioavailability Score |
0.55 |
Caco2 |
0 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.473 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.293 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |